Company Overview
| Stock Name | Hke Holdings |
|---|---|
| Stock Code | 01726 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 以新加坡為基地的醫療保健行業專業承建商,具備輻射防護工程專業知識,主要為新加坡的醫院及診所提供綜合設計及建築服務,亦從事維護及其他服務以及工具及材料銷售。 |
| Listing Date | 2018-04-18 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港干諾道中168-200號信德中心招商局大廈24樓2414-2416室 |
| Business Address (Hong Kong) | 香港中環花園道3號中國工商銀行大廈16樓1604-6室 |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | hwakoon.com |
| Share Registrar | 宝德隆 |
| Registrar Contact | (852)2153 1688 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 0.55 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | RMB 0.01 / shares |
| Offer Period | 2018-03-28 to 2018-04-04 |
| Global Offering Shares | 200,000,000 shares |
| HK Public Offer Shares (Initial) | 20,000,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 180,000,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 800,000,000 shares |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | No |
| Total Global Offering Size | HK$ 110,000,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 757.8M |
| Est. Threshold | HK$ 9.73B |
| Analysis Result | HK market cap below threshold, need +1184% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利約5.2百萬新加坡元 |
| Period-End Cash Balance | 新加坡元4.0百萬元 |
| Listing Expenses | ~HK$ 26,000,000 |
| Listing Expenses / Funds Raised | ~23.64% |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
RMB
Income Statement
| Item | 2015-06 | 2016-06 | 2017-06 | 2017-09 |
|---|---|---|---|---|
| Revenue | 13,244,503 | 9,793,083 | 14,937,418 | 4,034,961 |
| Cost of sales | -7,971,327 | -6,187,490 | -8,432,129 | -2,258,059 |
| Gross profit | 5,273,176 | 3,605,593 | 6,505,289 | 1,776,902 |
| Other income and gains, net | 23,160 | 50,639 | 48,468 | 8,201 |
| Administrative expenses | -1,173,671 | -634,716 | -618,196 | -177,699 |
| Net finance costs | -2,327 | -225 | 0 | 0 |
| Profit before tax | 4,120,338 | 3,021,291 | 6,068,386 | -191,155 |
| Income tax expense | -653,575 | -340,367 | -917,764 | -247,831 |
| Profit for the year | 3,466,763 | 2,680,924 | 5,150,622 | -438,986 |
Balance Sheet
| Item | 2015-06 | 2016-06 | 2017-06 | 2017-09 |
|---|---|---|---|---|
| Cash and cash equivalents | 3,751,835 | 1,095,434 | 4,011,269 | 3,939,661 |
| Trade and bills receivables | 1,968,802 | 2,322,159 | 3,477,865 | 4,334,638 |
| Total current assets | 6,129,262 | 6,853,825 | 9,759,183 | 11,843,571 |
| Total assets | 6,791,641 | 7,539,348 | 10,505,979 | 12,565,905 |
| Total current liabilities | 3,193,673 | 2,654,059 | 2,365,232 | 4,865,356 |
| Total liabilities | 3,208,092 | 2,670,687 | 2,390,884 | 4,889,660 |
| Total equity | 3,583,549 | 4,868,661 | 8,115,095 | 7,676,245 |
| Equity attributable to owners | 3,583,549 | 4,868,661 | 8,115,095 | 7,676,245 |
| Interest-bearing borrowings | 15,777 | 0 | 0 | 0 |
Cash Flow Statement
| Item | 2015-06 | 2016-06 | 2017-06 | 2017-09 |
|---|---|---|---|---|
| Net cash from operating activities | 3,481,951 | 1,563,527 | 3,683,923 | 105,814 |
| Net cash from investing activities | -3,993 | -2,056,547 | 1,952,882 | -177,558 |
| Net cash from financing activities | -1,468,774 | -2,163,381 | -2,720,970 | 136 |
| Net increase in cash | 2,009,184 | -2,656,401 | 2,915,835 | -71,608 |
| Depreciation of PP&E | 78,271 | 76,253 | 98,582 | 29,531 |
| Purchase of PP&E | -3,993 | -99,397 | -159,855 | -5,069 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 0.56 |
|---|---|
| First Day Open | HK$ 0.7 |
| First Day Change | 1.82% |
| First Day Volume | 289780000.0 |
| First Day Turnover | 179169000.0 |
| Use of Proceeds | 1、約38.6百萬港元,約45.9%,用于在截至2019年6月30日止年度前購置建筑面積約900至1,000平方呎、作工場及辦公室用途的額外物業,以(a)應對人力擴充計劃;及(b)獲得更多制造輻射防護產品的空間;
2、約24.4百萬港元,約29.1%,用于通過招募更多員工擴充人力,以(a)減少我們對分包服務的需求及由此產生的相關費用;及(b)增加我們內部承接更多綜合設計及建筑服務項目的能力;
3、約5.5百萬港元,約6.5%,用于增加我們就出具以我們的客戶為受益人的履約保函提供資金的儲備金;
4、約5.8百萬港元,約6.9%,用于購置(a)額外汽車,以應對我們運輸需求的增加;及(b)額外機械,以進行起重及木工工程;
5、約2.6百萬港元(相當于約0.4百萬新加坡元),約3.1%,用于通過宣傳我們在新加坡醫療相關建筑行業的品牌知名度及市場形象加大市場推廣力度;
6、約7.1百萬港元(相當于約1.1百萬新加坡元),約8.5%,用作一般營運資金。 |
Underwriting Syndicate
Sole Sponsor (1)
Dakin Capital Limited CE BGC821
Joint Bookrunners (1)
HEAD & SHOULDERS SECURITIES LIMITED CE AFS455
Joint Lead Managers (1)
HEAD & SHOULDERS SECURITIES LIMITED CE AFS455
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 洪坤明 | — |
| Company Secretary | 鄭家穗 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 控股股東洪先生、王先生及許先生作為一組一致行動的控股股東,透過Skylight Illumination間接持有本公司合共75%權益(600,000,000股)。 |
|---|




